This phase II, double-blind, randomized, placebo-controlled multicenter study will investigate the efficacy and safety of trastuzumab emtansine in...
This randomized phase III trial studies axillary lymph node dissection to see how well it works compared to axillary radiation therapy in treating...
Aspirin in Preventing Recurrence of Cancer in Patients With Node Positive HER2 Negative Stage II-III Breast Cancer After Chemo, Surgery, and/or...
MLN0128 in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy
The study will also further characterize the safety of CDX-011 treatment in this patient population.
This study will test the theory that therapy designed for each individual's tumor will improve outcomes over standard of care.
This is a global, multicenter, open-label extension study.
This study is an open label, randomized, multicenter trial of MM-302 plus trastuzumab.
This is a randomized, multi-center, multinational, open-label, active-controlled, parallel design study.
